Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 13Thoracic 2Lymphoid 2Gastrointestinal 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 2

Interventions

Rituximab 530Cyclophosphamide 425Vincristine 219Doxorubicin 192fludarabine phosphate 177Etoposide 167Prednisone 166fludarabine 162Methotrexate 162Cytarabine 157Filgrastim 125Dexamethasone 123Lenalidomide 121Granulocyte Colony-Stimulating Factor 116Whole-Body Irradiation 107Mycophenolic Acid 99ibrutinib 97Bendamustine Hydrochloride 91Tacrolimus 88Melphalan 85Calcium Dobesilate 82Peripheral Blood Stem Cell Transplantation 80Bortezomib 80Busulfan 78obinutuzumab 64ofatumumab 59Radiotherapy 57Cyclosporine 57Antilymphocyte Serum 55Brentuximab Vedotin 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × antineoplaston A10 × Lymphoid × Clear all
NCT00003498 2021-01-22

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Burzynski Research Institute

Phase 2 Terminated
5 enrolled 5 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00003499 2020-11-24

Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Burzynski Research Institute

Phase 2 Completed
31 enrolled 6 charts
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡